PARP1 and central nervous system cancer: Since it was reported that variations in cellular NAD+ levels can alter the proteins that interact with PARP1 (87), we used the BioID approach by expressing PARP1-BirA in glioma cells to determine the spontaneous and NAD+-regulated PARP1-interactome.